Fleet Phospho-Soda Kidney Damage Lawsuits Filed in Georgia

Three new lawsuits were filed last week against C.B. Fleet Company, Inc. in the U.S. District Court for the Northern District of Georgia on behalf of plaintiffs who allegedly suffered severe kidney damage from Fleet Phospho-soda laxatives used to cleanse their bowels before a colonoscopy.

The cases join dozens of other lawsuits pending throughout the United States that claim the over-the-counter oral sodium phosphate solution can cause a form of kidney damage known as acute phosphate nephropathy when it is used at double doses to clear out the bowels.

A Fleet Phospho-soda recall was issued in December 2008 after the FDA warned that the laxative should not be used as a bowel cleanser due to the kidney damage side effects.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

The new complaints were filed on May 26, 2009 on behalf of plaintiffs from Washington, Tennessee and Pennsylvania. Each of the plaintiffs state that they took double doses of the laxative as part of a colonoscopy prep and later developed a kidney injury.

The kidney damage lawsuits allege that the manufacturer was aware of the potential Fleet Phospho-soda risks, yet continued to market the laxative for use at higher doses during colonoscopy prep and failed to warn consumers or the medical community.

Fleet Phospho-soda has been safely used as a laxative for decades, but over the past 15 years, C.B. Fleet began marketing the product for use at double doses before colonoscopy examinations or other surgical procedures that require the bowels to be clear. The high doses are what has been linked to the kidney damage problems.

Last month, hearings were held before the U.S. Judicial Panel on Multidistrict Litigation in response to C.B. Fleet’s request to have all Fleet Phospho-soda kidney damage lawsuits filed in different federal districts consolidated before one judge for pretrial litigation.

At the time the motion was filed in April, there were 63 Fleet Phospho-soda lawsuits pending throughout the United States, with 38 in federal court spread among 16 districts in 13 different states. Following the recall of Fleet Phospho-soda, the manufacturer indicated that the number of new cases filed has increased substantially, leading to their request for an MDL, or Multidistrict Litigation, to be formed.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal
BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal (Posted 2 days ago)

A BioZorb lawsuit has been filed by several breast cancer survivors after the BioZorb implants moved out of place and failed to dissolve int he body, requiring surgical removal.

Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October
Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October (Posted 2 days ago)

A U.S. District Court judge has scheduled a fairness hearing for October in order to determine whether final approval should be granted to a $25 million Philips CPAP recall settlement agreement, which would pay former users $25 million to pay for future medical monitoring needs.